First Time Loading...

Mayne Pharma Group Ltd
ASX:MYX

Watchlist Manager
Mayne Pharma Group Ltd Logo
Mayne Pharma Group Ltd
ASX:MYX
Watchlist
Price: 7.12 AUD -0.28% Market Closed
Updated: May 10, 2024

Mayne Pharma Group Ltd
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Mayne Pharma Group Ltd
Pre-Tax Income Peer Comparison

Comparables:
RCE
NEU
BOT
PBP
C
CU6

Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
Mayne Pharma Group Ltd
ASX:MYX
Pre-Tax Income
-AU$269.7m
CAGR 3-Years
-26%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
Recce Pharmaceuticals Ltd
ASX:RCE
Pre-Tax Income
-AU$11.3m
CAGR 3-Years
5%
CAGR 5-Years
-46%
CAGR 10-Years
N/A
Neuren Pharmaceuticals Ltd
ASX:NEU
Pre-Tax Income
AU$205.1m
CAGR 3-Years
N/A
CAGR 5-Years
132%
CAGR 10-Years
N/A
Botanix Pharmaceuticals Ltd
ASX:BOT
Pre-Tax Income
-AU$14.6m
CAGR 3-Years
-17%
CAGR 5-Years
-3%
CAGR 10-Years
-24%
Probiotec Ltd
ASX:PBP
Pre-Tax Income
AU$13m
CAGR 3-Years
15%
CAGR 5-Years
19%
CAGR 10-Years
19%
C
Clarity Pharmaceuticals Ltd
ASX:CU6
Pre-Tax Income
-AU$24.5m
CAGR 3-Years
-52%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Mayne Pharma Group Ltd's Pre-Tax Income?
Pre-Tax Income
-269.7m AUD

Based on the financial report for Jun 30, 2023, Mayne Pharma Group Ltd's Pre-Tax Income amounts to -269.7m AUD.

What is Mayne Pharma Group Ltd's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 5Y
-10%

Over the last year, the Pre-Tax Income growth was -85%. The average annual Pre-Tax Income growth rates for Mayne Pharma Group Ltd have been -26% over the past three years , -10% over the past five years .